Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
21 October 2019 | Story Thabo Kessah | Photo Tshepo Moeketsi
Qwaqwa research research
Mamokete Mokhatla (SRC: International Students Council), Pulane Xaba (Assistant: Afromontane Research Unit), Dr Hagenmeier, Morena Ntsane Mopeli, Prof Pearl Sithole, Chief Mlati, Kanego Mogotsi (Internationalisation: Qwaqwa Campus), and Prof Joseph Francis.

Communities are beginning to wonder if universities exist for themselves or for their communities. This is the view shared by Prof Pearl Sithole, Campus Vice-Principal: Academic and Research, during the opening of the two-day Travelling Seminar that was recently hosted on the Qwaqwa Campus. 

Research in communities

“This event is well-placed, considering what many communities are currently going through. We must ask ourselves what we are doing with and for our communities. We must be careful to not only reap data from them, but to be scientific in a way that accommodates our communities and allows the African and indigenous agenda into the world of science,” she added.

Providing background to the concept of homestays, the Director: Institute for Rural Development at the University of Venda, Prof Joseph Francis, acknowledged the role played by communities in research.

 “This seminar seeks to develop a testable framework for homestays; a concept enabling postgraduate students to be placed with rural families while conducting research in the area. It is also aimed at giving birth to a vibrant, community-based rural and regional development network connecting grassroots communities, business, government, and non-governmental stakeholders,” he said.

“We do not only train students for local deployment and within national borders. It is important to produce an ‘all-weather’ graduate who stands out wherever they are. Graduates must ask themselves, ‘what in me stands out among the rest?’ As a student and researcher, never see yourself as being confined to the space where you are,” he added.

Students as ambassadors

Cornelius Hagenmeier, Director: Office of International Affairs at the University of the Free State, said for internationalisation to work, it has to be inclusive and create student ambassadors. “As this seminar will show, our networks of stakeholder communities go beyond the national confines and borders. We must strive, through this project, to create ambassadors of the university, of communities, of the broader South Africa and Africa,” he said.

Participants in the seminar were academics and postgraduate students from both the Universities of the Free State and Venda. Also present were community and traditional leaders from Qwaqwa and the Vhembe District in Limpopo. 

News Archive

National Department of Health invests R53.5 million in UFS laboratory
2016-02-04

Description: Dr Derek Litthauer Tags: Dr Derek Litthauer

Dr Derek Litthauer
Photo: Supplied

This year has started off on a high note for Dr Derek Litthauer and his team at the South African National Control Laboratory (NCL) for Biological Products. The National Department of Health has awarded the NCL a contract to the value of R53.5 million to continue testing vaccines for the next three years.

Vaccines are biological medicines used to ensure healthy populations by preventing many diseases. The World Health Organization (WHO) estimates that, worldwide, about 5.2 million children under six years old die annually. Of these deaths, 29% are vaccine preventable. Research has revealed that vaccines prevent about 6 million deaths each year globally. Safe and effective vaccines are essential public health tools, which are strictly regulated internationally. It is the NCL’s responsibility to perform quality control testing on all vaccines to be used on humans in South Africa.

This laboratory, the only one of its kind in Africa, receives samples of vaccines from manufacturers and importers for rigorous evaluation and testing. No vaccine may be used in South Africa without a release certificate issued by the Control Lab, certifying that the vaccine is suitable for human use.

The contract is a commitment to ensuring that only vaccines of the highest quality are used in South Africa.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept